Literature DB >> 28976421

High-risk prescribing and opioid overdose: prospects for prescription drug monitoring program-based proactive alerts.

Peter Geissert1, Sara Hallvik2, Joshua Van Otterloo3, Nicole O'Kane2, Lindsey Alley2, Jody Carson2, Gillian Leichtling2, Christi Hildebran2, Wayne Wakeland1, Richard A Deyo4.   

Abstract

To develop a simple, valid model to identify patients at high risk of opioid overdose-related hospitalization and mortality, Oregon prescription drug monitoring program, Vital Records, and Hospital Discharge data were linked to estimate 2 logistic models; a first model that included a broad range of risk factors from the literature and a second simplified model. Receiver operating characteristic curves, sensitivity, and specificity of the models were analyzed. Variables retained in the final model were categories such as older than 35 years, number of prescribers, number of pharmacies, and prescriptions for long-acting opioids, benzodiazepines or sedatives, or carisoprodol. The ability of the model to discriminate between patients who did and did not overdose was reasonably good (area under the receiver operating characteristic curve = 0.82, Nagelkerke R = 0.11). The positive predictive value of the model was low. Computationally simple models can identify high-risk patients based on prescription history alone, but improvement of the predictive value of models may require information from outside the prescription drug monitoring program. Patient or prescription features that predict opioid overdose may differ from those that predict diversion.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28976421      PMCID: PMC5893429          DOI: 10.1097/j.pain.0000000000001078

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  9 in total

1.  A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients.

Authors:  Hsien-Yen Chang; Noa Krawczyk; Kristin E Schneider; Lindsey Ferris; Matthew Eisenberg; Tom M Richards; B Casey Lyons; Kate Jackson; Jonathan P Weiner; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2019-06-07       Impact factor: 4.492

2.  Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids.

Authors:  Di Liang; Yuyan Shi
Journal:  Drug Alcohol Rev       Date:  2019-07

3.  Comparing person-level matching algorithms to identify risk across disparate datasets among patients with a controlled substance prescription: retrospective analysis.

Authors:  Lindsey M Ferris; Jonathan P Weiner; Brendan Saloner; Hadi Kharrazi
Journal:  JAMIA Open       Date:  2022-03-30

Review 4.  Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data.

Authors:  Iraklis Erik Tseregounis; Stephen G Henry
Journal:  Transl Res       Date:  2021-03-21       Impact factor: 10.171

5.  Record Linkage Approaches Using Prescription Drug Monitoring Program and Mortality Data for Public Health Analyses and Epidemiologic Studies.

Authors:  Sarah Nechuta; Sutapa Mukhopadhyay; Shanthi Krishnaswami; Molly Golladay; Melissa McPheeters
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

6.  Ensemble learning to predict opioid-related overdose using statewide prescription drug monitoring program and hospital discharge data in the state of Tennessee.

Authors:  Michael Ripperger; Sarah C Lotspeich; Drew Wilimitis; Carrie E Fry; Allison Roberts; Matthew Lenert; Charlotte Cherry; Sanura Latham; Katelyn Robinson; Qingxia Chen; Melissa L McPheeters; Ben Tyndall; Colin G Walsh
Journal:  J Am Med Inform Assoc       Date:  2021-12-28       Impact factor: 7.942

7.  Clinical utility and perils of prescription drug monitoring program-based alert systems.

Authors:  Juan M Hincapie-Castillo; Yu-Jung Wei; Almut G Winterstein
Journal:  Pain       Date:  2018-04       Impact factor: 7.926

8.  Reply.

Authors:  Peter Geissert; Sara Hallvik; Nicole O'Kane; Joshua Van Otterloo; Lindsey Alley; Jody Carson; Gillian Leichtling; Christi Hildebran; Wayne Wakeland; Richard A Deyo
Journal:  Pain       Date:  2018-04       Impact factor: 7.926

9.  Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories.

Authors:  Georgia C Richards; Jeffrey K Aronson; Kamal R Mahtani; Carl Heneghan
Journal:  Br J Pain       Date:  2021-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.